Unknown

Dataset Information

0

Carnitine Diminishes Etoposide Toxic Action on Spermatogonial Self-renewal and Sperm Production in Adult Rats Treated in the Prepubertal Phase.


ABSTRACT: The aim of this study was to investigate carnitine action against negative effects of etoposide on stem/progenitor spermatogonia and on sperm production. Carnitine (250 mg/kg body weight/day) and etoposide (5 mg/kg body weight/day) were administered from 25-days postpartum to 32-days postpartum. Testes were collected at 32-days postpartum, 64-days postpartum, and 127-days postpartum, and submitted to the immuno-labeling of UTF1, SOX2, and PLZF proteins to identify undifferentiated spermatogonia populations. At 127-days postpartum, sperm were collected for analysis. Carnitine+etoposide group showed a higher numerical density of spermatogonia labeled for all studied proteins at 64-days postpartum (critical age) compared to the etoposide group. Moreover, there was an improvement of spermatic parameters and sperm DNA integrity in rats of the carnitine+etoposide group in comparison with rats of the etoposide group. The results suggest that carnitine improves the self-renewal of undifferentiated spermatogonia and promotes a partial protection on them, alleviating the etoposide harmful late effects and leading to an enhancement of the sperm parameters in adulthood.

SUBMITTER: Okada FK 

PROVIDER: S-EPMC7226625 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Carnitine Diminishes Etoposide Toxic Action on Spermatogonial Self-renewal and Sperm Production in Adult Rats Treated in the Prepubertal Phase.

Okada Fatima Kazue FK   Stumpp Taiza T   Miraglia Sandra Maria SM  

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20200331 5


The aim of this study was to investigate carnitine action against negative effects of etoposide on stem/progenitor spermatogonia and on sperm production. Carnitine (250 mg/kg body weight/day) and etoposide (5 mg/kg body weight/day) were administered from 25-days postpartum to 32-days postpartum. Testes were collected at 32-days postpartum, 64-days postpartum, and 127-days postpartum, and submitted to the immuno-labeling of UTF1, SOX2, and PLZF proteins to identify undifferentiated spermatogonia  ...[more]

Similar Datasets

| S-EPMC5467043 | biostudies-literature
| S-EPMC3466062 | biostudies-literature
| S-EPMC5315423 | biostudies-literature
| S-EPMC2654929 | biostudies-other
| S-EPMC6448598 | biostudies-literature
2023-05-15 | GSE222105 | GEO
| S-EPMC5204355 | biostudies-literature
| S-EPMC7674451 | biostudies-literature
| S-EPMC3150879 | biostudies-literature
| S-EPMC11704178 | biostudies-literature